Literature DB >> 7473608

Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice.

J G Falls1, B L Blake, Y Cao, P E Levi, E Hodgson.   

Abstract

Hepatic flavin-containing monooxygenase (FMO) activity of microsomes from adult CD-1, Swiss-Webster, C57BL/6, and DBA/2 mice was found to be significantly higher in females than in males. Based on protein and mRNA levels in CD-1 mice, FMO forms responsible for the gender difference in FMO activity were FMO1 and FMO3. FMO1 expression was two to three times higher in female mice compared with males; FMO3, however, which was expressed at levels equivalent to FMO1 in female mice, was not detected in males. The expression of FMO5 was approximately equal in both sexes. FMO2 and FMO4 transcripts were not evident in hepatic mRNA from mice. Protein and mRNA levels appear to be coregulated with regard to gender-selective or gender-specific expression of FMO1 or FMO3, respectively. FMO5, which demonstrates no gender-selective expression in mice, may be regulated by different mechanisms. Examination of protein levels among Swiss-Webster, C57BL/6, and DBA/2 strains revealed a gender-dependent expression of FMO isozymes identical to the CD-1 strain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473608     DOI: 10.1002/jbt.2570100308

Source DB:  PubMed          Journal:  J Biochem Toxicol        ISSN: 0887-2082


  18 in total

Review 1.  Flavin-containing monooxygenases in aging and disease: Emerging roles for ancient enzymes.

Authors:  Ryan Rossner; Matt Kaeberlein; Scott F Leiser
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

2.  Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice.

Authors:  S G Kulkarni; A A Pegram; P C Smith
Journal:  AAPS PharmSci       Date:  2000

3.  Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice.

Authors:  A Joseph Bloom; Pramod Upadhyaya; Evan D Kharasch
Journal:  Biopharm Drug Dispos       Date:  2019-05-20       Impact factor: 1.627

4.  Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation models.

Authors:  Jun Zhang; Madhusudana R Chaluvadi; Rob Reddy; Meike S Motika; Terrilyn A Richardson; John R Cashman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-12-16       Impact factor: 3.922

5.  Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver.

Authors:  G Bryzgalova; H Gao; B Ahren; J R Zierath; D Galuska; T L Steiler; K Dahlman-Wright; S Nilsson; J-A Gustafsson; S Efendic; A Khan
Journal:  Diabetologia       Date:  2006-02-04       Impact factor: 10.122

6.  RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice.

Authors:  Lai Peng; Julia Y Cui; Byunggil Yoo; Sumedha S Gunewardena; Hong Lu; Curtis D Klaassen; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2013-09-30       Impact factor: 3.922

7.  Hepatic gene expression variations in response to high-fat diet-induced impaired glucose tolerance using RNAseq analysis in collaborative cross mouse population.

Authors:  H J Abu-Toamih Atamni; G Kontogianni; I Binenbaum; R Mott; H Himmelbauer; H Lehrach; A Chatziioannou; Fuad A Iraqi
Journal:  Mamm Genome       Date:  2019-10-24       Impact factor: 2.957

8.  Genome-level analysis of genetic regulation of liver gene expression networks.

Authors:  Daniel Gatti; Akira Maki; Elissa J Chesler; Roumyana Kirova; Oksana Kosyk; Lu Lu; Kenneth F Manly; Robert W Williams; Andy Perkins; Michael A Langston; David W Threadgill; Ivan Rusyn
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes.

Authors:  Rachel M Novick; Ann M Mitzey; Mark S Brownfield; Adnan A Elfarra
Journal:  J Pharmacol Exp Ther       Date:  2009-03-23       Impact factor: 4.030

10.  Metabolism and pharmacokinetics of the anti-tuberculosis drug ethionamide in a flavin-containing monooxygenase null mouse.

Authors:  Amy L Palmer; Virginia L Leykam; Andrew Larkin; Sharon K Krueger; Ian R Phillips; Elizabeth A Shephard; David E Williams
Journal:  Pharmaceuticals (Basel)       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.